Coagulation Factor IX Activity (Factor IX)
Vitamin K-dependent serine protease zymogen synthesized in the liver and activated by Factor XIa or the tissue factor-VIIa complex.
Standard vs. Optimal Reference Ranges% Activity
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
60 - 140%
General reference distribution across unselected commercial populations.
70 - 130%
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Factor IXa forms the intrinsic tenase complex with Factor VIIIa on phospholipid membranes to activate Factor X into Factor Xa.
Differential Diagnosis
Elevated Levels (Factor IX High)
- •Normal intrinsic coagulation flux
Low Levels (Factor IX Low)
- •Hemophilia B (Factor IX deficiency / Christmas disease)
- •Warfarin anticoagulation
- •Severe vitamin K deficiency
- •Hepatic synthetic failure
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Factor IX
- Targeted organ system imaging or functional dynamic testing related to intrinsic pathway serine protease
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Coagulation Factor IX Activity - The New England Journal of Medicine (2021). PMID: 34090124
- [2]Factor IX Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Coagulation Factor IX Activity (Factor IX) into overall healthspan optimization.